PNO INNOVATION GMBH

Their core work

PNO Innovation is a Munich-based innovation consultancy specializing in EU-funded project management, dissemination, and communication services. Rather than conducting core research, they support consortia with exploitation strategies, stakeholder engagement, impact assessment, and administrative coordination across a wide range of sectors. Their consistent role as participant or third party across 30 highly diverse H2020 projects — from neuroscience to hydrogen energy to customs security — indicates they are a professional services firm embedded in EU research ecosystems, not a domain-specific research organization.

What they specialise in

How they've shifted over time

In 2015–2018, PNO Innovation's portfolio was heavily anchored in health — particularly aging, dementia, and neurodegenerative diseases (PRECIOUS, SENSE-Cog, PHAGO, STIPED). From 2019 onward, the portfolio diversified significantly into energy (hydrogen systems, power-to-X), security, climate services, and AI-enabled applications while maintaining health as a core sector. This broadening suggests growing capacity and client base rather than a strategic pivot, consistent with a consultancy expanding its service reach.

PNO Innovation is expanding beyond its health-heavy origins into energy, AI, and climate projects, positioning itself as a sector-agnostic innovation services partner for large EU consortia.

How they like to work

PNO Innovation never leads consortia — across 30 projects, they served exclusively as participant (17) or third party (13), indicating a deliberate support role. With 412 unique partners across 44 countries, they operate as a high-connectivity hub rather than a loyal-partner organization, joining new consortia regularly. This makes them easy to onboard: they are experienced in integrating into diverse teams and managing cross-cultural consortium dynamics.

With 412 unique consortium partners spanning 44 countries, PNO Innovation has one of the broadest partner networks among German private companies in H2020. Their reach is truly pan-European with no strong geographic concentration, reflecting their role as a versatile service provider that plugs into any consortium.

What sets them apart

PNO Innovation's value lies in its sector-agnostic project support capability — few organizations can credibly contribute to both a hepatitis B vaccine trial and a hydrogen combustion demonstrator. Their extensive network of 412 partners makes them a valuable connector for consortium builders who need a reliable German partner with proven administrative and dissemination track records. For coordinators assembling a consortium, PNO brings professional project management and impact communication without competing for the scientific or technical core of the work.

Highlights from their portfolio

• CURSOR
  Largest single EC contribution (EUR 589,881), focused on miniaturized robotics for search and rescue — an unusually technical project for a consultancy.
• AIMS-2-TRIALS
  Long-running IMI-style project (2018–2026) on autism biomarkers and clinical trials, demonstrating sustained engagement in complex multi-year health initiatives.
• DAREnet
  Significant funding (EUR 519,327) for a resilience exchange network along the Danube — showcases their capacity to manage cross-border networking projects.